News

Novavax (NASDAQ: NVAX) fell behind in the original coronavirus vaccine race as rivals Pfizer and Moderna brought their products to market. The biotech launched its vaccine a year-and-a-half later in

Shares of Ardelyx (NASDAQ: ARDX) were down more than 12% as of 3:30 p.m. on Wednesday. The healthcare company, which has a chronic kidney disease (CKD) drug that is awaiting approval later this

Shares of Sharecare (NASDAQ: SHCR) were up more than 26% as of 2 p.m. ET on Wednesday after the digital healthcare company said it had received a proposal from a private equity firm to buy the

Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease.

Dialysis

Shares of Fresenius Medical Care (NYSE: FMS) were down more than 18% as of noon ET on Wednesday. The healthcare company's shares are up a little more than 5% so far this year. The drop came because

Stock markets looked poised to continue their winning ways on Wednesday morning, as stock index futures were higher across the board. Investors will get a look today at the latest thought process

Medical device giant Abbott Laboratories (NYSE: ABT) hasn't performed well in the past year. The company has had to deal with several issues that affected its results and its public image, notably

Despite strong gains for the broader market this year, AT&T (NYSE: T) stock continues to struggle. The company's share price is down nearly 19% so far in 2023. With the stock trading at low earnings

Intellia Therapeutics (NASDAQ: NTLA) has announced a good deal of positive news in recent months, from progress in clinical trials to an expanded partnership with big biotech Regeneron

Shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) were up more than 15% as of 11 a.m. on Tuesday after Express Scripts said it will give certain clients access to Lexicon's drug Inpefa. The healthcar

Gene-editing specialist Intellia Therapeutics (NASDAQ: NTLA) has caught the attention of Cathie Wood. The founder and CEO of Ark Invest, an investment management firm focused on investing in

Shares of Scilex Holdings (NASDAQ: SCLX) were up around 14% as of 2:30 p.m. ET on Monday. The healthcare stock is still down more than 55% this year.

Scilex makes non-opioid pain management products

Shares of Tango Therapeutics (NASDAQ: TNGX) were down more than 12% as of 11:15 a.m. on Monday. The healthcare stock is up more than 37% this year.

Tango is a clinical-stage biotech that focuses on

For income-seeking investors, the only thing better than a solid dividend stock is a beaten-down one whose shares can be bought on the dip. And while the market has largely recovered this year, some

The stock market has rendered its verdict on AT&T (NYSE: T) stock this year. While the S&P 500 is up around 10% year-to-date, shares of the telecom giant have tumbled roughly 20%.

There are some

Cathie Wood manages net assets of around $12 billion in her Ark Invest exchange-traded funds (ETFs). It's part of her job to keep close tabs on macroeconomic trends while also focusing on major

Gene editing is one of the most revolutionary trends in modern medicine. The potential to swap out a person's genes to eliminate and prevent diseases is here, and investors are keenly looking at

Smart investors are continually looking for new investment ideas. Sometimes, those ideas are so good that they're hard to pass up.

Three Motley Fool contributors think they've picked some stocks

Early on in the pandemic, Moderna and Pfizer beat smaller rival Novavax (NASDAQ: NVAX) to market with their coronavirus vaccines by a year or more in some countries. This head start offered them the

Shares of AT&T (NYSE: T) fell as much as 6% early Friday, then settled to close down around 2.7% following a report that the company is weighing whether to divest its stake in DirecTV next year.

Shares of medical technology company Koninklijke Philips (NYSE: PHG) were down more than 9% as of 10:45 on Friday. The company announced on Thursday that the Food and Drug Administration (FDA) is

The Sphere in Las Vegas just had its grand opening (via a U2 concert, kicking off a two-month residency in South Nevada), and the internet is abuzz with footage from the tech-powered entertainment

There are excellent reasons to invest in dividend stocks beyond their regular payouts. Growing a dividend requires companies to deliver solid financial results regularly, and the longer a

Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) are two top pharmaceutical companies that are pursuing growth opportunities. Pfizer is looking to build up and diversify its business as its COVID